Hospira Issues a Voluntary Nationwide Recall for Labetalol Hydrochloride Injection, USP, Due to the Potential of Cracked Glass
13-04-2020
Hospira, Inc., a Pfizer company, is voluntarily recalling 3 lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial (NDC 0409-2267-20), and one lot of Labetalol Hydrochloride Injection, USP, Novaplus® (NDC 0409-2267-25) to the...
Read more